New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Niki BioSolutions, Inc. (NIKI) vs Pulmatrix, Inc. (PULM)
- Niki BioSolutions, Inc. NIKI 1.68 +5.00%
- Pulmatrix, Inc. PULM 1.40 +4.48%
Niki BioSolutions, Inc. and Pulmatrix, Inc. are both Biotechnology companies. Niki BioSolutions, Inc. and Pulmatrix, Inc. are of similar size ($5.0M and $4.9M). Niki BioSolutions, Inc. grew revenue faster over the last twelve months: 42.6% against 6.96%. Pulmatrix, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Niki BioSolutions, Inc. leads on 7 and Pulmatrix, Inc. on 6.
Valuation
Profitability
| Metric | NIKI | PULM | Biotechnology median |
|---|---|---|---|
| Gross margin | (87.96%) | 100.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (921.74%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (172.27%) | (51.58%) |
| Return on assets | 0.00% | (119.43%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack